Informed-money record
LXRX · LEXICON PHARMACEUTICALS, INC.
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
8
Bearish filings
0
Named actors
2
Disclosed $ (bull / bear)
$2.7M / $0
Recent disclosures
8 of 8 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-02-25 | Director DEBBANE RAYMOND | bought | $3K | SEC ↗ |
| 2026-02-23 | Director DEBBANE RAYMOND | bought | $147K | SEC ↗ |
| 2026-02-20 | Director DEBBANE RAYMOND | bought | $148K | SEC ↗ |
| 2026-02-19 | Director DEBBANE RAYMOND | bought | $72K | SEC ↗ |
| 2026-02-18 | Director DEBBANE RAYMOND | bought | $176K | SEC ↗ |
| 2026-02-17 | Director DEBBANE RAYMOND | bought | $101K | SEC ↗ |
| 2026-02-13 | Director DEBBANE RAYMOND | bought | $76K | SEC ↗ |
| 2026-02-02 | Director Artal Group S.A. | bought | $2.0M | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals